CIK 0001662774
- Non-accelerated filer
- Smaller reporting company
IRulya Therapeutics Inc.
Sign in to watch- Ticker
- IRLA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 901024039
- Phone
- +1 203-208-8994
- Business address
- 101 COLLEGE STREET, SUITE 210, NEW HAVEN, CT, 06510
- Former names
- Quince Therapeutics, Inc., Cortexyme, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-12-11 | McDowell Caryn Gordon Chief Legal & Adm. Officer | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2020-12-10 | Holsinger Leslie Executive Vice President | Option exercise | +3,500 | $0.27 | $945 | 3,500 |
| 2020-12-10 | Holsinger Leslie Executive Vice President | Option exercise · Stock Option (Right to Buy) | −3,500 | 106,794 | ||
| 2020-06-12 | EPIQ Capital Group, LLC IA/Managing Member of 10% Owne | Purchase | +2,440 | $44.06 | $108K | 2,860,967 |
| 2020-06-11 | EPIQ Capital Group, LLC IA/Managing Member of 10% Owne | Purchase | +6,600 | $44.32 | $293K | 2,858,527 |
| 2020-06-08 | YOUNG KEVIN Director | Grant or award · Stock Option (Right to Buy) | +11,029 | 11,029 | ||
| 2020-06-08 | Senner Christopher J. Director | Grant or award · Stock Option (Right to Buy) | +11,029 | 11,029 | ||
| 2020-06-08 | RYAN UNA S Director | Grant or award · Stock Option (Right to Buy) | +11,029 | 11,029 | ||
| 2020-06-08 | McLoughlin Margaret Director | Grant or award · Stock Option (Right to Buy) | +11,029 | 11,029 | ||
| 2020-06-08 | Lamond David Director | Grant or award · Stock Option (Right to Buy) | +11,029 | 11,029 | ||
| 2020-06-04 | Lamond David Director | Purchase | +13,609 | $42.13 | $573K | 1,711,593 |
| 2020-06-04 | Lamond David Director | Purchase | +10,642 | $43.32 | $461K | 1,722,235 |
| 2020-06-04 | Lamond David Director | Purchase | +24,874 | $43.88 | $1.1M | 1,747,109 |
| 2020-06-03 | PFIZER INC 10% owner | Sale | −370,000 | $40.18 | $14.9M | 2,879,973 |
| 2020-05-27 | Detke Michael J. Chief Medical Officer | Option exercise | +5,515 | $6.91 | $38K | 28,261 |
| 2020-05-27 | Detke Michael J. Chief Medical Officer | Option exercise · Stock Option (Right to Buy) | −5,515 | 104,091 | ||
| 2020-05-22 | EPIQ Capital Group, LLC IA/Managing Member of 10% Owne | Purchase | +2,085 | $55.90 | $117K | 2,851,927 |
| 2020-05-21 | EPIQ Capital Group, LLC IA/Managing Member of 10% Owne | Purchase | +520 | $55.80 | $29K | 2,849,842 |
| 2020-05-20 | EPIQ Capital Group, LLC IA/Managing Member of 10% Owne | Purchase | +5,668 | $58.00 | $329K | 2,848,905 |
| 2020-05-20 | EPIQ Capital Group, LLC IA/Managing Member of 10% Owne | Purchase | +417 | $57.22 | $24K | 2,849,322 |
Page 14 of 18 · 350 trades